IPO registrations (S-1, F-1) · Registrants

EASTGATE BIOTECH CORP

SEC CIK
1099574 · filings on EDGAR ↗
Name on the registration
EASTGATE ACQUISITIONS CORP
Former names
EASTGATE ACQUISITIONS CORP (1999–2015)
Registration
Form S-1, first filed 2012-11-20, last 2014-07-22; 2 initial registrations, 7 amendments
Outcome
Declared effective 2013-10-16
Industry (SIC)
Investors, NEC 6799
Incorporated in
NV
Business address
2681 EAST PARLEYS WAY - SUITE 204, Salt Lake City, UT 84109
EIN
87-0639378
EDGAR entity type
operating
Insiders and CEO pay
EASTGATE BIOTECH CORP on the corporate pages

Offering terms

Shares offered
16,754,028
Listing
OTC under the symbol ESAQ

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 11

FiledFormWhat it isName as filedEDGAR
2012-11-20S-1S-1 (registration)EASTGATE ACQUISITIONS CORP0001099574-12-000019 ↗
2013-01-29S-1/AS-1/A (amendment)EASTGATE ACQUISITIONS CORP0001099574-13-000003 ↗
2013-05-14S-1/AS-1/A (amendment)EASTGATE ACQUISITIONS CORP0001099574-13-000014 ↗
2013-06-27S-1/AS-1/A (amendment)EASTGATE ACQUISITIONS CORP0001099574-13-000016 ↗
2013-07-29S-1/AS-1/A (amendment)EASTGATE ACQUISITIONS CORP0001099574-13-000018 ↗
2013-09-05S-1/AS-1/A (amendment)EASTGATE ACQUISITIONS CORP0001551163-13-000103 ↗
2013-09-26S-1/AS-1/A (amendment)EASTGATE ACQUISITIONS CORP0001551163-13-000113 ↗
2013-10-16EFFECTEFFECT (declared effective)EASTGATE ACQUISITIONS CORP9999999995-13-002980 ↗
2014-07-01S-1S-1 (registration)EASTGATE ACQUISITIONS CORP0001551163-14-000207 ↗
2014-07-22S-1/AS-1/A (amendment)EASTGATE ACQUISITIONS CORP0001551163-14-000222 ↗
2014-08-11EFFECTEFFECT (declared effective)EASTGATE ACQUISITIONS CORP9999999995-14-002455 ↗

Prospectus pages read 1

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-07-22S-1/Aregistration statement16,754,028-OTC ESAQ0primary document; shares headlinedocument ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
GLUSKIN ANNA EDirector; Director,OfficerCEO42012–2015
Hasanagic Mirjana MiraDirector; Director,OfficerPresident; PRESIDENT42012–2015
Lukian BrianDirector,OfficerCFO42012–2015
SCHWARZ JOSEPHOfficerCHIEF SCIENTIST; CSO62012–2015
WEISSPAPIR MICHAELOfficerCHIEF MEDICAL OFFICER; CMO52012–2015
TGT INVESTMENT MANAGEMENT INC.TenPercentOwner12014
PERRI ROSE COfficerPresident12015

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
SEC filerEASTGATE BIOTECH CORPSEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Investors, NEC, UT first:

More with this interest.

In other datasets, the same topic (Finance) in UT:

Interests: Investors, NEC · Finance